TABLE 3.
Penicillin susceptibility (no. of isolates) | AST methoda | No. of mEs | No. (%) of mEs with: |
||
---|---|---|---|---|---|
Penicillin | T/S | Erythromycin | |||
Susceptible (204) | Phoenix | 2 | 0 | 1 (0.5) | 0 |
Vitek 2* | 8 | 3 (1.6) | 2 (1.0) | 1 (0.5) | |
MicroScan | 4 | 0 | 2 (1.0) | 1 (0.5) | |
Etest | 4 | 3 (1.5) | 1 (0.5) | 0 | |
Total | 18 | ||||
Intermediate (67) | Phoenix | 18 | 12 (17.9) | 2 (3.0) | 0 |
Vitek 2** | 11 | 7 (10.9) | 3 (4.7) | 1 (1.6) | |
MicroScan | 9 | 2 (3.0) | 4 (6.0) | 0 | |
Etest | 6 | 2 (3.0) | 3 (4.5) | 0 | |
Total | 44 | ||||
Resistant (40) | Phoenix | 9 | 2 (5.0) | 3 (7.5) | 0 |
Vitek 2*** | 8 | 6 (16.7) | 1 (2.8) | 1 (2.8) | |
MicroScan | 6 | 2 (5.0) | 1 (2.0) | 0 | |
Etest | 3 | 2 (5.0) | 1 (2.0) | 0 | |
Total | 26 |
*, n = 192; **, n = 64; ***, n = 36.